NCT06986967

Brief Summary

The purpose of this study is to compare brain function after surgical circulatory arrest using either antegrade perfusion or retrograde perfusion.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
10mo left

Started Apr 2025

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress56%
Apr 2025Mar 2027

Study Start

First participant enrolled

April 18, 2025

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

April 29, 2025

Completed
24 days until next milestone

First Posted

Study publicly available on registry

May 23, 2025

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2027

Last Updated

August 15, 2025

Status Verified

August 1, 2025

Enrollment Period

1.6 years

First QC Date

April 29, 2025

Last Update Submit

August 13, 2025

Conditions

Keywords

Antegrade PerfusionRetrograde PerfusionBrain PerfusionCirculatory Arrest

Outcome Measures

Primary Outcomes (1)

  • Change in neurocognitive function as measured by the Montreal Cognitive Assessment (MoCA)

    The MoCA is a brief screening tool used to assess cognitive function. It consists of 30 tasks covering various cognitive domains, including attention, memory, visuospatial abilities, and executive function. The total score ranges from 0 to 30, where a higher score indicates better cognitive function.

    Baseline to 4 weeks

Secondary Outcomes (2)

  • Effect of Antegrade Perfusion (ACP) vs Retrograde Perfusion (RCP) on brain white matter patency

    Baseline, prior to discharge from hospital (up to 7 days), and at 4 weeks

  • Effect of Antegrade Perfusion (ACP) vs Retrograde Perfusion (RCP) on functional connectivity

    Baseline and at 4 weeks

Study Arms (2)

Arm 1: Antegrade Perfusion

ACTIVE COMPARATOR

In antegrade perfusion, the surgeon accesses one of two arteries that branch off from the aorta (the artery that delivers blood to the rest of the body) to provide blood to the brain.

Procedure: Antegrade Perfusion

Arm 2: Retrograde Perfusion

ACTIVE COMPARATOR

In retrograde perfusion, the surgeon accesses the superior vena cava (large vein bringing blood back to the heart) to supply blood to the brain.

Procedure: Retrograde Perfusion

Interventions

Procedure in which the surgeon accesses one of two arteries that branch off from the aorta to provide blood to the brain.

Arm 1: Antegrade Perfusion

Procedure in which the surgeon accesses the superior vena cava to supply blood to the brain.

Arm 2: Retrograde Perfusion

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \> 18 years of age
  • Participant's that are scheduled for elective proximal aortic reconstructive surgery (ascending aorta + aortic valve or root) with concomitant proximal hemi-arch replacement via median sternotomy

You may not qualify if:

  • \< 18 years of age
  • history of symptomatic cerebrovascular disease, e.g., prior stroke with residual deficit
  • current alcoholism (\> 2 drinks/day)
  • current psychiatric illness requiring pharmacotherapy
  • current drug abuse (any illicit drug use in the past 3 months)
  • hepatic insufficiency (liver function tests \> 1.5 times the upper limit of normal)
  • severe pulmonary insufficiency (requiring home oxygen therapy)
  • renal failure (serum creatinine \> 2.0 mg/dL)
  • claustrophobic fear
  • unable to read and thus unable to complete the cognitive testing
  • pregnant women
  • patients who score \<19 om the Montreal Cognitive Assessment (MoCA) or ≥27 on the baseline Center for Epidemiological Studies Depression (CES-D) scale
  • patients who have pre-existing unsafe implants for 3 Tesla magnetic resonance imaging (MRI)
  • Patients who have received chemotherapy in the last 12 months or radiation to the brain

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Duke Univeristy

Durham, North Carolina, 27710, United States

NOT YET RECRUITING

Duke Univeristy

Durham, North Carolina, 27710, United States

RECRUITING

Study Officials

  • Joseph Mathew, M.D.

    Duke University

    STUDY CHAIR

Central Study Contacts

Kelly Rodden, BSN

CONTACT

Bonita Hilliard, RPM

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The neuroimaging personnel will be blinded to the assignment of the subject.
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 29, 2025

First Posted

May 23, 2025

Study Start

April 18, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

March 1, 2027

Last Updated

August 15, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

Locations